Immunogenicity Assessment
About Us
- Leadership
- Careers
Partner
Press
- News
- Events
- Publications
- Blog
Contact Us

Tregitopes: The active ingredient in IVIG-mediated tolerance induction?

by Adam | Oct 21, 2016 | 0 comments

Submit a Comment

You must be logged in to post a comment.

Search

Recent Posts

The Platinum Vaccine & Change is Good!
EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO
Smarter Tools, Safer Therapies: Supporting the FDA’s Roadmap with in silico Immunogenicity Assessment
The Amsterdam Immunogenicity & Tolerance Seminar: 2025
The Westin Immunogenicity Seminar

Recent Comments

No comments to show.

Join our newsletter

Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CMO, Dr. Annie De Groot.

Email Address

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.Accept Decline